Studies of anandamide accumulation inhibitors in cerebellar granule neurons: Comparison to inhibition of fatty acid amide hydrolase

Journal of Molecular Neuroscience

Volumn 33, Issue 1, 2007, Pages 18-24

  Hillard, Cecilia J ^a   Shi, Leyu ^a   Tuniki, Venugopal Raju ^b   Falck, John R ^b   Campbell, William B ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

AM1172; AM404; N arachidonylethanolamine; OMDM 2; Palmitoylethanolamide; UCM707; VDM 11

Indexed keywords

AM 1172; ANANDAMIDE; CANNABINOID RECEPTOR ANTAGONIST; FATTY ACID AMIDASE; N (3 FURYLMETHYL)ARACHIDONAMIDE; N (4 HYDROXY 2 METHYLPHENYL)ARACHIDONAMIDE; N (4 HYDROXYPHENYL)ARACHIDONAMIDE; OMDM 2; PALMIDROL; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BRAIN MEMBRANE; CEREBELLUM; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG POTENCY; DRUG SYNTHESIS; ENZYME INHIBITION; EXTRACELLULAR SPACE; GRANULE CELL; HYDROLYSIS; IC 50; INTRACELLULAR SPACE; LINEAR REGRESSION ANALYSIS; MALE; MOUSE; NERVE CELL; NONHUMAN; PROTEIN LOCALIZATION;

AMIDOHYDROLASES; ANIMALS; ARACHIDONIC ACIDS; BENZAMIDES; BENZYL COMPOUNDS; CELLS, CULTURED; CEREBELLUM; ENDOCANNABINOIDS; FEMALE; FURANS; MALE; MICE; NEURONS; POLYUNSATURATED ALKAMIDES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 35348851360     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12031-007-0045-0     Document Type: Article

References (21)

1. Beltramo, M., di Tomaso, E., & Piomelli, D. (1997a). Inhibition of anandamide hydrolysis in rat brain tissue by (E)-6-(bromomethylene) tetrahydro-3-(1-naphthalenyl)-2H-pyran-2-one. Federation of European Biochemical Societies letters, 403, 263-267.
2. Beltramo, M., Stella, N., Calignano, A., Lin, S. Y., Makriyannis, A., & Piomelli, D. (1997b). Functional role of high-affinity anandamide transport, as revealed by selective inhibition. Science, 277, 1094-1097.
3. Day, T. A., Rakhshan, F., Deutsch, D. G., & Barker, E. L. (2001). Role of fatty acid amide hydrolase in the transport of the endogenous cannabinoid anandamide. Molecular Pharmacology, 59, 1369-1375.
4. De Petrocellis, L., Bisogno, T., Davis, J. B., Pertwee, R. G., & Di Marzo, V. (2000). Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: Inhibitors of anandamide uptake with negligible capsaicin-like activity. Federation of European Biochemical Societies letters, 483, 52-56.
5. Fegley, D., Kathuria, S., Mercier, R., Li, C., Goutopoulos, A., Makriyannis, A., et al. (2004). Anandamide transport is independent of fatty-acid amide hydrolase activity and is blocked by the hydrolysis-resistant inhibitor AM1172. Proceedings of the National Academy of Sciences of the United States of America, 101, 8756-8761.
6. Fowler, C. J., Tiger, G., Ligresti, A., Lopez-Rodriguez, M. L., & Di Marzo, V. (2004). Selective inhibition of anandamide cellular uptake versus enzymatic hydrolysis - a difficult issue to handle. European Journal of Pharmacology, 492, 1-11.
7. Glaser, S. T., Abumrad, N. A., Fatade, F., Kaczocha, M., Studholme, K. M., & Deutsch, D. G. (2003). Evidence against the presence of an anandamide transporter. Proceedings of the National Academy of Sciences of the United States of America, 100, 4269-4274.
8. Hillard, C. J., & Jarrahian, A. (2003). Cellular accumulation of anandamide: Consensus and controversy. British Journal of Pharmacology, 140, 802-808.
9. Hillard, C. J., & Jarrahian, A. (2005). Accumulation of anandamide: Evidence for cellular diversity. Neuropharmacology, 48, 1072-1078.
10. Hillard, C. J., Wilkison, D. M., Edgemond, W. S., & Campbell, W. B. (1995). Characterization of the kinetics and distribution of N-arachidonylethanolamine (anandamide) hydrolysis by rat brain. Biochimica et Biophysica Acta, 1257, 249-256.
11. Hillard, C. J., Edgemond, W. S., Jarrahian, A., & Campbell, W. B. (1997). Accumulation of N-arachidonoylethanolamine (anandamide) into cerebellar granule cells occurs via facilitated diffusion. Journal of Neurochemistry, 69, 631-638.
12. Jacobsson, S. O., & Fowler, C. J. (2001). Characterization of palmitoylethanolamide transport in mouse Neuro-2a neuroblastoma and rat RBL-2H3 basophilic leukaemia cells: Comparison with anandamide. British Journal of Pharmacology, 132, 1743-1754.
13. Jarrahian, A., Manna, S., Edgemond, W. S., Campbell, W. B., & Hillard, C. J. (2000). Structure-activity relationships among N-arachidonylethanolamine (Anandamide) head group analogues for the anandamide transporter. Journal of Neurochemistry, 74, 2597-2606.
14. Lang, W., Qin, C., Lin, S., Khanolkar, A. D., Goutopoulos, A., Fan, P., et al. (1999). Substrate specificity and stereoselectivity of rat brain microsomal anandamide amidohydrolase. Journal of Medicinal Chemistry, 42, 896-902.
15. Lopez-Rodriguez, M. L., Viso, A., Ortega-Gutierrez, S., Lastres-Becker, I., Gonzalez, S., Fernandez-Ruiz, J., et al. (2001). Design, synthesis and biological evaluation of novel arachidonic acid derivatives as highly potent and selective endocannabinoid transporter inhibitors. Journal of Medicinal Chemistry, 44, 4505-4508.
16. Lopez-Rodriguez, M. L., Viso, A., Ortega-Gutierrez, S., Fowler, C. J., Tiger, G., de Lago, E., et al. (2003). Design, synthesis, and biological evaluation of new inhibitors of the endocannabinoid uptake: Comparison with effects on fatty acid amidohydrolase. Journal of Medicinal Chemistry, 46, 1512-1522.
17. Ortar, G., Ligresti, A., De Petrocellis, L., Morera, E., & Di Marzo, V. (2003). Novel selective and metabolically stable inhibitors of anandamide cellular uptake. Biochemical Pharmacology, 65, 1473-1481.
18. Ortega-Gutierrez, S., Hawkins, E. G., Viso, A., Lopez-Rodriguez, M. L., & Cravatt, B. F. (2004). Comparison of anandamide transport in FAAH wild-type and knockout neurons: Evidence for contributions by both FAAH and the CB1 receptor to anandamide uptake. Biochemistry, 43, 8184-8190.
19. Piomelli, D., Beltramo, M., Glasnapp, S., Lin, S. Y., Goutopoulos, A., Xie, X. Q., et al. (1999). Structural determinants for recognition and translocation by the anandamide transporter. Proceedings of the National Academy of Sciences, 96, 5802-5807.
20. Ruiz-Llorente, L., Ortega-Gutierrez, S., Viso, A., Sanchez, M. G., Sanchez, A. M., Fernandez, C., et al. (2004). Characterization of an anandamide degradation system in prostate epithelial PC-3 cells: Synthesis of new transporter inhibitors as tools for this study. British Journal of Pharmacology, 141, 457-467.
21. Vandevoorde, S., & Fowler, C. J. (2005). Inhibition of fatty acid amide hydrolase and monoacylglycerol lipase by the anandamide uptake inhibitor VDM11: Evidence that VDM11 acts as an FAAH substrate. British Journal of Pharmacology, 145, 885-893.